Yourgene Offers Premaitha An Asian Reprieve From Illumina Patent Tussle

Noninvasive prenatal testing specialist Premaitha Health has agreed to acquire Taiwan's Yourgene Bioscience, enabling the UK company to expand its presence in Asia. The deal also offers an important market that has not been tainted by ongoing patent litigation between Premaitha and US next-generation sequencing firm Illumina.

More from In Vitro Diagnostics

More from Diagnostics